199 related articles for article (PubMed ID: 33602932)
21. Depletion of HPV16 early genes induces autophagy and senescence in a cervical carcinogenesis model, regardless of viral physical state.
Hanning JE; Saini HK; Murray MJ; Caffarel MM; van Dongen S; Ward D; Barker EM; Scarpini CG; Groves IJ; Stanley MA; Enright AJ; Pett MR; Coleman N
J Pathol; 2013 Nov; 231(3):354-66. PubMed ID: 23913724
[TBL] [Abstract][Full Text] [Related]
22. Type 2 human papillomavirus E7 attenuates E-cadherin expression in human keratinocytes.
Song JY; Park YM; Choi SY
J Microbiol; 2021 Jun; 59(6):616-625. PubMed ID: 33779957
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers.
Lace MJ; Anson JR; Klussmann JP; Wang DH; Smith EM; Haugen TH; Turek LP
J Virol; 2011 Feb; 85(4):1645-54. PubMed ID: 21123375
[TBL] [Abstract][Full Text] [Related]
24. Exposure to Microbial Metabolite Butyrate Prolongs the Survival Time and Changes the Growth Pattern of Human Papillomavirus 16 E6/E7-Immortalized Keratinocytes in Vivo.
Li M; McGhee EM; Shinno L; Lee K; Lin YL
Am J Pathol; 2021 Oct; 191(10):1822-1836. PubMed ID: 34214507
[TBL] [Abstract][Full Text] [Related]
25. Stranglehold on the spindle assembly checkpoint: the human papillomavirus E2 protein provokes BUBR1-dependent aneuploidy.
Tan CL; Teissier S; Gunaratne J; Quek LS; Bellanger S
Cell Cycle; 2015; 14(9):1459-70. PubMed ID: 25789401
[TBL] [Abstract][Full Text] [Related]
26. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
27. The Human Papillomavirus 16 E7 Oncoprotein Attenuates AKT Signaling To Promote Internal Ribosome Entry Site-Dependent Translation and Expression of c-MYC.
Strickland SW; Vande Pol S
J Virol; 2016 Jun; 90(12):5611-5621. PubMed ID: 27030265
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of the epidermal growth factor receptor by erlotinib prevents immortalization of human cervical cells by Human Papillomavirus type 16.
Woodworth CD; Diefendorf LP; Jette DF; Mohammed A; Moses MA; Searleman SA; Stevens DA; Wilton KM; Mondal S
Virology; 2011 Dec; 421(1):19-27. PubMed ID: 21982220
[TBL] [Abstract][Full Text] [Related]
29. HPV16 oncoproteins induce MMPs/RECK-TIMP-2 imbalance in primary keratinocytes: possible implications in cervical carcinogenesis.
Cardeal LB; Boccardo E; Termini L; Rabachini T; Andreoli MA; di Loreto C; Longatto Filho A; Villa LL; Maria-Engler SS
PLoS One; 2012; 7(3):e33585. PubMed ID: 22438955
[TBL] [Abstract][Full Text] [Related]
30. Genome-Wide Transcriptome Analysis of Human Papillomavirus 16-Infected Primary Keratinocytes Reveals Subtle Perturbations Mostly due to E7 Protein Expression.
Bienkowska-Haba M; Luszczek W; Zwolinska K; Scott RS; Sapp M
J Virol; 2020 Jan; 94(3):. PubMed ID: 31748387
[TBL] [Abstract][Full Text] [Related]
31. HPV-inactive cell populations arise from HPV16-transformed human keratinocytes after p53 knockout.
Abboodi F; Buckhaults P; Altomare D; Liu C; Hosseinipour M; Banister CE; Creek KE; Pirisi L
Virology; 2021 Feb; 554():9-16. PubMed ID: 33321328
[TBL] [Abstract][Full Text] [Related]
32. The papillomavirus E7 proteins.
Roman A; Munger K
Virology; 2013 Oct; 445(1-2):138-68. PubMed ID: 23731972
[TBL] [Abstract][Full Text] [Related]
33. The Asian-American variant of human papillomavirus type 16 exhibits higher activation of MAPK and PI3K/AKT signaling pathways, transformation, migration and invasion of primary human keratinocytes.
Hochmann J; Sobrinho JS; Villa LL; Sichero L
Virology; 2016 May; 492():145-54. PubMed ID: 26945151
[TBL] [Abstract][Full Text] [Related]
34. Contributions of viral oncogenes of HPV-18 and hypoxia to oxidative stress and genetic damage in human keratinocytes.
Hochmann J; Millán M; Hernández P; Lafon-Hughes L; Aiuto N; Silva A; Llaguno J; Alonso J; Fernández A; Pereira-Prado V; Sotelo-Silveira J; Bologna-Molina R; Arocena M
Sci Rep; 2023 Oct; 13(1):17734. PubMed ID: 37853061
[TBL] [Abstract][Full Text] [Related]
35. Oncogenic potential diverge among human papillomavirus type 16 natural variants.
Sichero L; Sobrinho JS; Villa LL
Virology; 2012 Oct; 432(1):127-32. PubMed ID: 22748253
[TBL] [Abstract][Full Text] [Related]
36. Genomic Signatures in HPV-Associated Tumors.
Hussain SS; Lundine D; Leeman JE; Higginson DS
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696429
[TBL] [Abstract][Full Text] [Related]
37. Activation of telomerase by HPVs.
Katzenellenbogen RA
Virus Res; 2017 Mar; 231():50-55. PubMed ID: 27863966
[TBL] [Abstract][Full Text] [Related]
38. STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle.
Morgan EL; Wasson CW; Hanson L; Kealy D; Pentland I; McGuire V; Scarpini C; Coleman N; Arthur JSC; Parish JL; Roberts S; Macdonald A
PLoS Pathog; 2018 Apr; 14(4):e1006975. PubMed ID: 29630659
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous human papillomavirus E7 type-specific effects on differentiation and proliferation of organotypic skin cultures.
Westphal K; Akgül B; Storey A; Nindl I
Cell Oncol; 2009; 31(3):213-26. PubMed ID: 19478389
[TBL] [Abstract][Full Text] [Related]
40. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]